IMBOLC PARTNERS
IMBOLC PARTNERS is a Pre-seed, Seed, Series A, Series B and Series C+ fund in the US writing $100K checks into AI, Climate, Enterprise, surgical-devices, insurance, biotechnology, environmental-services and health-and-wellness.
- Stages
- Pre-seed, Seed, Series A, Series B, Series C+
- Sectors
- AI, Climate, Enterprise, surgical-devices, insurance, biotechnology, environmental-services, health-and-wellness
- Check size
- $100K
- Invests in
- US-wide
- Round role
- Leads rounds
- Actively investing
- Yes
- Founded
- 2014
Thesis
Imbolc Partners is a venture capital firm founded in 2014 and based in Boston, Massachusetts. They focus on providing pre-seed capital, often being the first institutional investor in a company. Their strategy involves investing in smaller deals, niche markets, and capital-efficient companies that have a clear path to revenue and strong M&A potential. They emphasize a fast-paced approach with limited bureaucracy and a 30% principal commitment. The firm's investment thesis centers on early-stage companies, specifically pre-seed and seed rounds. Imbolc Partners typically invests $100,000 per company and often leads these early rounds. Having operated as an angel group for a decade, they launched Imbolc Partners I in 2024. Their total assets under management are not publicly disclosed. The firm's founding investment in a regional records management firm resulted in a 9x return.
Common questions
Does IMBOLC PARTNERS invest at the Pre-seed stage?
Yes. IMBOLC PARTNERS lists Pre-seed, Seed, Series A, Series B and Series C+ among the stages it invests in.
What check size does IMBOLC PARTNERS write?
IMBOLC PARTNERS writes $100K checks.
Where does IMBOLC PARTNERS invest?
IMBOLC PARTNERS invests in the US.